FCM
PRCT icon

FirstWave Capital Management’s Procept Biorobotics PRCT Stock Holding History

FirstWave Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.26M Buy
144,408
+64,069
+80% +$1.6M 1.44% 21
2026
Q1 		$2.01M Sell
80,339
-39,184
-33% -$1.1M 2.14% 15
2025
Q4 		$3.76M Buy
+119,523
New +$3.96M 2.23% 17

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

FirstWave Capital Management's PRCT Position: Q2 2026 in Review

FirstWave Capital Management increased its Procept Biorobotics (PRCT) stake by 80% in Q2 2026, buying an estimated $1.6M and bringing the position to 144,408 shares worth $3.26M. The position accounts for 1.44% of the portfolio, ranked #21.

FirstWave Capital Management first reported a position in PRCT in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.76M in Q4 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • FirstWave Capital Management held 144,408 shares of Procept Biorobotics worth $3.26M as of Q2 2026.
  • FirstWave Capital Management bought 64,069 Procept Biorobotics shares in Q2 2026, an estimated $1.6M.
  • Procept Biorobotics made up 1.44% of FirstWave Capital Management's portfolio in Q2 2026, its #21 holding.
  • FirstWave Capital Management first reported a position in Procept Biorobotics in Q4 2025 and has held it in 3 quarters since.
  • FirstWave Capital Management's Procept Biorobotics position peaked at $3.76M in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on FirstWave Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.